Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?
about
Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel diseaseDrug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrationsPortal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies.Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations.Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.Therapeutic trials in childhood ALL: what's their future?Recent advances in management of acute leukaemia.Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanineClinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease.Human red blood cells: rheological aspects, uptake, and release of cytotoxic drugs.The thiopurines: an update.Review article: thiopurines in inflammatory bowel disease.Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism.Toxicity and response to thiopurines in patients with inflammatory bowel disease.Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression.Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.High variation of tioguanine absorption in patients with chronic active Crohn's disease.Drug interaction between infliximab and azathioprine in patients with Crohn's disease.Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy.6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.Critical assessment of thioguanine treatment for inflammatory bowel diseases: Is it time to rehabilitate this treatment?Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease.
P2860
Q24631869-19902469-1A50-4011-B178-6C902F41F3B6Q28258977-675306FB-588F-4641-BADE-2227D4171EDDQ28367546-170F141F-8500-4DD6-9641-FD40D794DBB6Q33363427-7F9D7777-27E8-47FD-89EA-FEFF670DFC61Q33388076-0F3DB01F-3F5B-4551-926C-48460F12482BQ33499963-5137FA1A-AFCD-4B7A-B02A-8FAFC34A6D11Q33503259-15834747-E21F-4809-AB11-0AB90BDFF2D7Q33624061-2CEDA94C-2796-49A2-9208-A21D7653CB28Q33893055-236FC67C-8B6C-4D35-8048-2D1ED58D73A0Q33930802-4CF1D119-2512-4225-95C4-73FFD1654EA7Q35036160-FBE30A65-30B3-4FCB-BEE9-DDCA2A7D0872Q35596702-690522BF-FD11-4897-85C8-A89EEDA510B7Q35843499-1C6AEFDB-73BC-4C87-B70E-7FF504ABC729Q36305435-EF14BD0E-71AD-4E4C-AF72-F54A361358ACQ36570796-C0D5D692-D01B-42BA-AEB9-88D5E06FFCA9Q36988021-E3646B2D-CD7E-4102-B959-A209906966C0Q37600072-13282B8D-77E6-421B-95BE-F013E82DC59BQ38443981-E706DE25-0506-473B-8AB4-F91E54864994Q40551481-BDF6E7C1-CF43-47D8-A192-FCDF084C6785Q43714765-8CF0C085-6D82-4EE8-9B4C-EBCAF075EB5AQ44099068-86E140B9-D5C5-4CAF-9CF3-87B5DD26F4F8Q44148231-E1A318C4-1629-4B7B-AF16-8BA80A9A8EFAQ44517210-6771C4B1-4A73-4264-90CE-66E7555F48F7Q44654800-9CE981E4-BD1F-4957-994D-F5E8EC8938CCQ44932093-67EECC03-68DA-4C60-AF5F-B67339AF6A31Q46844249-7731E284-47DA-4D96-A60D-5464113A8AE7Q46982269-03859EB3-93B2-4DA9-AD90-21C9615DD82DQ48188262-16BED072-EC24-45AD-A903-66A67D66269BQ50708004-878010D2-1E5E-4360-B3BC-2E37C15B61DF
P2860
Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?
description
1993 nî lūn-bûn
@nan
1993 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Is 6-thioguanine more appropri ...... acute lymphoblastic leukaemia?
@ast
Is 6-thioguanine more appropri ...... acute lymphoblastic leukaemia?
@en
type
label
Is 6-thioguanine more appropri ...... acute lymphoblastic leukaemia?
@ast
Is 6-thioguanine more appropri ...... acute lymphoblastic leukaemia?
@en
prefLabel
Is 6-thioguanine more appropri ...... acute lymphoblastic leukaemia?
@ast
Is 6-thioguanine more appropri ...... acute lymphoblastic leukaemia?
@en
P2093
P2860
P356
P1476
Is 6-thioguanine more appropri ...... acute lymphoblastic leukaemia?
@en
P2093
Lilleyman JS
P2860
P2888
P304
P356
10.1038/BJC.1993.311
P407
P577
1993-07-01T00:00:00Z
P5875
P6179
1033249097